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- What is the key question? 
With recruitment independent of contact with health services, age or underlying diagnoses, 
what is the relationship between chronic breathlessness and health-related quality of life 
across the general adult population? 
 
- What is the bottom line? 
As chronic breathlessness worsens across the population, so do the physical and mental 
component summary scores of the Short Form 12 (SF-12) health-related quality of life at 
clinically and statistically significant levels in every age group.   
 
- Why read on? 
 
Chronic breathlessness is prevalent across the community and as safe, effective evidence-
based symptomatic treatments are available, it is important for clinicians to identify more 
often populations with this debilitating state.   
 ABSTRACT  
Little is known about the impact of chronic breathlessness (modified Medical Research 
Council (mMRC) score ≥2 for most days, at least three of the last six months) on health-
related quality of life (HrQoL; Short Form-12 (SF-12)). 3005 adults from randomly selected 
households were interviewed face-to-face in South Australia.   
 
mMRC ≥2 community prevalence was 2.9%. Adjusted analyses showed clinically 
meaningful and statistically significant decrements of physical and mental components of SF-
12 (mean SF-12 summary scores in physical (-13.0 [-16.0,-10.2]) and mental (-10.7 [-13.7,-
7.8]) components compared to people with mMRC=0) as chronic breathlessness severity 
increased, across five age groupings.  
  
INTRODUCTION 
Chronic breathlessness is a distinct clinical syndrome [1] most frequently attributed to 
respiratory disease. Chronic breathlessness has a profound impact on people’s day-to-day 
function, emotional wellbeing, their families, and correlates with poorer prognosis. As 
chronic breathlessness worsens, people limit their function to avoid breathlessness and 
ultimately may become housebound.  
  
Data are lacking on the impact of increasingly severe chronic breathlessness in the general 
population on health-related quality of life (HrQoL) [2] although there is a consistent 
relationship between increasing severity of chronic breathlessness and worsening (HrQoL) 
by: 
- disease (COPD; chronic heart failure; interstitial lung disease; cystic fibrosis; lung 
cancer); 
- age (the elderly); and  
- prognosis (the end of life).  
 
The aim was to explore the impact of chronic breathlessness on people’s self-reported HrQoL 
across the population. The null hypotheses were that there would be no relationship between 
intensity of chronic breathlessness (modified Medical Research Council (mMRC)) [3] scores 
and physical and mental component scores (PCS, MCS) of the Short Form-12 (SF-12). [4] 
  
METHODS 
Data were collected in the 2015 South Australian Health Omnibus Survey (HOS), a multi-
stage, systematic, clustered area sample of households in which face-to-face interviews were 
held only with the occupant who most recently had a birthday. Data were weighted to 
national normative data (five year age group; sex; rurality; and household size).  
 
HrQoL 
The SF-12 is a 12 item questionnaire. Higher scores reflect better HrQoL. [5] A clinically 
meaningful worsening may be as little as 3 points (PCS) or 3.5 points (MCS) in people with 
cardio-respiratory diseases. [5] 
 
Breathlessness 
mMRC breathlessness scale is validated in this population. [3] Participants were asked if such 
breathlessness ‘affected them most days for at least 3 of the last 6 months’. A higher score 
reflects worse breathlessness. (Supplementary Table 1) Data were grouped into mMRC 0, 1 
or ≥2.  
 
Socio-demographics  
Demographic variables (nine year age groups; sex; educational attainment; rurality; 
employment; and current smoking status) were used in the analyses. 
 
Statistical analyses 
After analysis of univariable relationships, three multivariable linear regression models were 
created: unadjusted; adjusted for all available factors; and one excluding smoking status 
given its high correlation with chronic breathlessness. Data were also examined for the 
relationship between the two SF-12 sub-scales, increasing severity of breathlessness and age 
in five sub-groups (15-44;45-54;55-64;65-74;≥75). (See online supplement) 
 
Ethics  
The Ethics Committee of the South Australian Department of Health approved the study. 
Participants gave informed verbal consent. This paper’s reporting accords with Strengthening 
the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.[6] 
 
RESULTS 
Three thousand and five people participated (participation rate of 66.1%); 1466 were male 
(49.2%), 618 (20.7%) were aged ≥65 years and 2239 (75.1%) lived in the metropolitan area; 
460 (15.4%) were current smokers (Supplementary Table 2). Two hundred and sixty 
respondents had mMRC grade 1 breathlessness (8.7%) and 88 (2.9%) had grades 2-4. 
   
When compared with those who did not experience chronic breathlessness and adjusting for  
age, sex, socio-economic factors and smoking status, people with mMRC of 1 or ≥2 
breathlessness had reduced predicted mean physical (-7.2; 95% confidence interval (CI) -8.4, 
-5.7; -13.0; 95%CI -16.0,-10.2 respectively) and mental (-6.0; 95%CI -7.3, -4.8; -10.7 95%CI 
-13.7, -7.8 respectively) SF-12 component summary scores (Figure 1; Supplementary Tables 
2, 3).  
 
Across the population, there was a consistent clinically important and statistically significant 
worsening of physical and mental HrQoL with increasing severity of chronic breathlessness.  
In the sensitivity analysis, omitting smoking status did not change the magnitude or direction 
of findings.  
 
This pattern of decreasing physical and mental component scores of the SF-12 with 
increasing severity of breathlessness was seen in each of the five age sub-groups examined. 
(Figure 2; Supplementary Table 5) For the same severity of breathlessness, the older the 
respondent was, the greater the impact that chronic breathlessness had on both components of 
HrQoL.  
 
DISCUSSION 
For the first time in a whole adult population sample, this study shows that increasing 
severity of chronic breathlessness is associated with clinically important and statistically 
significant decrements in the physical and mental component scores of the SF-12. 
Importantly, recruitment was independent of health service contact, diagnoses or age.  
 
In sub-groups previously studied, similar patterns were seen. [7, 8] One longitudinal 
population study which accounted for co-morbidities and had correlation of physical findings 
at 12 years (n =3786; age 15-70) reported on moderate to severe persistent or incident 
breathlessness and impaired physical and mental HrQoL (SF-12) of the same magnitude. [8] 
To complement these findings, the current HOS study had no upper age limit, a definition for 
‘chronicity’ and covered all levels of mMRC.  
 
Worsening breathlessness and clinically and statistically worsening HrQoL (MCS SF-36) has 
been confirmed (n==1169; age ≥70). As age increased, so did prevalence and severity of 
breathlessness, likelihood of anxiety or depression and poorer physical function. [7] 
 
Using the EQ-5D-3L, HrQoL in 5,944 (56.8% response) patients registered with two general 
practices showed a strong relationship between COPD and worsening HrQoL. With 
breathlessness, all domains of the EQ-5D-3L (mobility, self-care, usual activities, 
pain/discomfort, anxiety/ depression, health status) were worse. [9] 
 
Limitations 
No health information about breathlessness’ aetiologies or their severity was collected nor 
were data on comorbidities, nor respondents’ physical or social functioning. The real 
community prevalence of chronic breathlessness will be higher than the figures outlined in 
this study, given that residential care facilities were not included in the survey and chronic 
breathlessness is likely to be a significant symptom in those settings.   
 
Strengths 
Tools validated in this population were used to measure outcomes of interest: HrQoL and 
breathlessness. A standardised definition of chronicity was used. Enrolling adults regardless 
of age adds to previous work.   
 
Implications for clinical practice / policy 
The high prevalence, impact on people’s daily lives and the strong association between 
increasing severity of chronic breathlessness and worsening HrQoL in the general population 
requires a fundamental re-evaluation of the way that chronic breathlessness is sought in 
clinical histories. Clinicians need to develop skills to enquire systematically about things that 
patients forego to avoid breathlessness in order to ‘see’ its true impact, especially as the 
evidence base improves for safe, currently available interventions to reduce chronic 
breathlessness. [10] Incorporating this evidence base into clinical practice will lessen the 
burden of chronic breathlessness in the community.  
 
Implications for future research 
Although mMRC is useful for defining breathlessness at a population level, there needs to be 
international consensus on a tool that can measure chronic breathlessness and is sensitive to 
change in routine clinical practice. To improve regression models, future research needs to 
account for other factors related to HrQoL including anxiety, depression, co-morbidities, and 
physiological measures including lung function.    
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Figure 1: Adjusted (age, sex, educational attainment, dwelling status, work status and smoking 
status) predicted mean health-related quality of life (physical and mental health components) 
scores (possible range 0-70) of the SF-12  by intensity of breathlessness (none – modified 
Medical Research Council (mMRC) breathlessness scale 0; 1; and ≥2.  
 
 
 
Figure 2: Comparison of level of chronic breathlessness (modified Medical Research Council 
Scale) by age group by the Health-related quality of life (SF-12) mental and physical 
component scores in the general population of South Australia 
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